Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care

British Medical Journal

Volumn 317, Issue 7157, 1998, Pages 516-519

  McClure, Samuel J ^a   Caruana, Lynn ^a   Davie, Andrew P ^a   Goldthorp, Steven ^b   McMurray, John J V ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b Walworth Road Surgery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; THIAZIDE DIURETIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; GENERAL PRACTICE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; ORAL DRUG ADMINISTRATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SECONDARY PREVENTION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0032558328     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.317.7157.516     Document Type: Article

References (28)

1. Garg R, Yusuf S. Overview of randomized trials of angiotensin converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450-6.
2. Nicklas JM, Pitl B, Timmis G, Breneman G, Jafri SM, Duvernoy WFC, et al. Effect of enalapril on mortality and the development of heart-failure in asymptomatic patients with reduced left-ventricular ejection fractions. N Engl J Med 1992;327:685-91.
3. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-21.
4. Wheeldon NM, Macdonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD. Echocardiography in chronic heart-failure in the community. Q J Med 1993;86:17-23.
5. Francis CM, Caruana L, Kearney P, Love M, Sutherland GR, Starkey IR, et al. Open access echocardiography in management of heart failure in the community. BMJ 1995;3:634-6.
6. Dargie HJ, McMurray JJV. Diagnosis and management of heart failure. BMJ 1994;308:321-8.
7. Davie AP, Love MP, McMurray JJV. Value of electrocardiography in identifying heart failure due to left ventricular systolic dysfunction. BMJ 1996;313:300-1.
8. Christian TF, Miller TD, Chareonthaitawee P, Hodge DO, O'Connor MK, Gibbons RJ. Prevalence of normal resting left ventricular function with normal rest electrocardiograms. Am J Cardiol 1997;79:1295-8.
9. Rihal CS, Davis KB, Kennedy JW, Gersh BJ. The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function. Am J Cardiol 1995;75:220-3.
10. Struthers AD. Prospects for using a blood sample in the diagnosis of heart failure. Q J Med 1995;273:1450-6.
11. Cowie MR, Struthers AD, Wood DA, Coats AJS, Thompson SG, Poole Wilson PA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-53.
12. Davidson NC, Coutie WJ, Struthers AD. N-terminal proatrial natriuretic peptide and brain natriuretic peptide are stable for up to 6 hours in whole blood in-vivo. Circulation 1995;91:1276-7.
13. Murdoch DR, Byrne J, Morton JJ, McDonagh TA, Robb SD, Clements S, et al. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart 1997;78:594-7.
14. Yamamoto K, Burnett JC, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-94.
15. Omland T, Aakvaag A, Vikmo H. Plasma cardiac natriuretic peptide determination as a screening test for the defection of patients with mild left ventricular impairment. Heart 1996;76:232-7.
16. Friedl W, Mair J, Thomas S, Pichler M, Puschendorf B. Natriuretic peptides and cyclic guanosine 3′,5′-monophosphate in asymptomatic and symptomatic left ventricular dysfunction. Heart 1996;76:129-36.
17. Davidson NC, Naas AA, Hanson JK, Kennedy NSJ, Coutie WJ, Struthers AD. Comparison of atrial natriuretic peptide. B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 1996;77:828-31.
18. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
19. Choy AMJ, Darbar D, Lang CC, Príngle TH, McNeill GP, Kennedy NSJ, et al. Detection of left ventricular dysfunction after acute myocardial-infarction - comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J 1994;72:16-22.
20. Willenheimer RB, Israelsson BA, Cline CMJ, Erhardt LR. Simplified echocardiography in the diagnosis of heart failure. Scand Cardiovasc J 1997;31:9-16.
21. Jensen-Urstad K, Bouvier F, Höjer J, Ruiz H, Hulting J, Samad B, et al. Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy. Am J Cardiol 1998;8:538-44.
22. Davis KM, Fish LC, Minaker KL, Elahi D. Atrial natriuretic peptide levels in the elderly differentiating normal ageing changes from disease. J Gerontol [A] Biol Sci Med Sci 1996;51:M95-101.
23. Buckley MG, Markandu ND, Miller MA, Sagnella GA, Macgregor GA. Plasma concentrations and comparisons of brain and atrial-natriuretic-peptide in normal subjects and in patients with essential-hypertension. J Hum Hypertens 1993;7:245-50.
24. Robb SD, McDonagh TA, Byrne J, Morton JJ, McMurray JJV, Dargie HJ. Plasma BNP and N-terminal ANP concentrations in individuals with ECG evidence of left ventricular hypertrophy: a population-based study. J Am Coll Cardiol 1997;29:965-77.
25. Lang CC, Prasad N, McAlpine HM, Macleod C, Lipworth BJ, Macdonald TM, et al. Increased plasma-levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J 1994;127:1635-6.
26. Northridge BD, McMurray J, Ray S, Jardine A, Dargie HJ. Release of atrial natriuretic factor after pericardiocentesis for malignant pericardial effusion. BMJ 1989;299:603-4.
27. Sanderson JE, Chan WWM, Hung YT, Chan SKW, Shum IOL, Raymond K, et al. Effect of low-dose beta-blockers on atrial and ventricular (b-type) natriuretic factor in heart-failure - a double-blind, randomised comparison of metoprolol and a third generation vasodilating beta-blocker. Br Heart J 1995;74:502-7.
28. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Fukai D, Maeda Y, et al. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure. Am Heart J 1997;134:910-6.